Research into leukemia drug makes National Cancer Institute doc a Sammies finalist
July 15, 2020
A breakthrough leukemia drug is on the market through a major drug manufacturer. But a research doctor at the National Cancer Institute made the discoveries that led to the drug in the first place. Now he’s expanding work on what are known as recombinant immunotoxins. For his work, Dr. Ira Pastan is a finalist in this year’s Service to America Medals program, and he joined Federal Drive with Tom Temin to discuss more.
Publication Type: In the News